Article Text

Download PDFPDF
Refractive errors in neurofibromatosis type 1 and type 2
  1. Arsen Akinci1,
  2. Golge Acaroglu2,
  3. Alev Guven3,
  4. Aydan Degerliyurt3
  1. 1Department of Pediatric Ophthalmology, Diskapi Children’s Hospital, Ankara, Turkey
  2. 2Department of Neuro-ophthalmology, Ulucanlar Eye Hospital, Ankara, Turkey
  3. 3Department of Pediatric Neurology, Diskapi Children’s Hospital, Ankara, Turkey
  1. Correspondence to: Dr A Akinci Department of Pediatric Ophthalmology, Diskapi Children’s Hospital, Dikmen Cad Yesilvadi Sok 7/5 Dikmen, 06410 Ankara, Turkey; arsenakinci{at}yahoo.com

Abstract

Objective: To document the prevalence of refractive errors in patients with neurofibromatosis type 1 (NF1) and type 2 (NF2) and to compare it with that of age- and sex-matched controls.

Methods: 82 patients with NF1, 21 patients with NF2 and 103 age- and sex-matched controls were evaluated in this prospective observational case–control study. Cycloplegic autorefraction and dilated fundus examination were performed. Myopia was defined as the spherical equivalent refraction of at least −0.50 diopters (D), hyperopia as the spherical equivalent refraction of at least 2.0 D and astigmatism as the cylinder of at least 1.0 D. Main outcome measures were refractive error, IQ, years of education, height, weight and body mass index (BMI).

Results: The prevalence of myopia was 23.1% in patients with NF1, 23.8% in patients with NF2 and 16.5% in age- and sex-matched controls. These differences were significant (p<0.03, p<0.03), and adjusting for intelligence, education, height, weight and BMI increased the significance of this finding (p<0.001, p<0.001). The prevalences of astigmatism and hyperopia were similar in both groups.

Conclusion: A high prevalence of myopia seems to be an additional feature of NF1 and NF2.

  • BMI, body mass index
  • NF1, neurofibromatosis type 1
  • NF2, neurofibromatosis type 2

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Published Online First 3 January 2007

  • Competing interests: None declared.